Stryker’s Chart Says ‘Buy’

SYK broke out from head-and-shoulders bottom on Friday


Stryker Corp. (NYSE:SYK) — This medical supply company offers a diverse array of medical technologies, including reconstructive, surgical, neurotechnology and spine products. It has had steady growth through acquisitions, the latest being the neurovascular division of Boston Scientific.

Its expected 10%-plus earnings growth for 2013 would put it in line to earn $4.50 per share versus $4.12 in 2012.

Technically SYK broke out from a head-and-shoulders bottom (reverse head-and-shoulders) on Friday with a price target of $62.

09 24 12 syk 300x208 Strykers Chart Says Buy
Click to Enlarge

chart key 300x84 Strykers Chart Says Buy

Article printed from InvestorPlace Media,

©2015 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.